A critical review of the development and importance of proteinaceous aggregates in animal models of Parkinson's disease: new insights into Lewy body formation-Reference-Cited by-同舟云学术

A critical review of the development and importance of proteinaceous aggregates in animal models of Parkinson's disease: new insights into Lewy body formation

Published:2004-06 Issue:4 Volume:10 Page:191-202
ISSN:1353-8020
Container-title:Parkinsonism & Related Disorders
language:en
Short-container-title:Parkinsonism & Related Disorders

Author:

Meredith Gloria E.,Halliday Glenda M.,Totterdell Susan

Publisher

Elsevier BV

Subject

Neurology (clinical),Geriatrics and Gerontology,Neurology

Reference86 articles.

1. α-synuclein and the Parkinson's disease-related mutant Ala53Thr-α-synuclein do not undergo proteasomal degradation in HEK293 and neuronal cells;Ancolio;Neurosci Lett,2000

2. Immunoelectron microscopic demonstration of NACP/alpha-synuclein epitopes on the filamentous component of Lewy bodies in Parkinson's disease and in dementia with Lewy bodies;Arima;Brain Res,1998

3. Experimental models of Parkinson's disease;Beal;Nat Rev Neurosci,2001

4. Impairment of the ubiquitin proteasome system by protein aggregation;Bence;Science,2001

5. Degradation of α-synuclein by proteasome;Bennett;J Biol Chem,1999

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Angiotensin type 1 receptor activation promotes neuronal and glial alpha-synuclein aggregation and transmission;npj Parkinson's Disease;2024-02-17

2. A sporadic Parkinson’s disease model via silencing of the ubiquitin–proteasome/E3 ligase component, SKP1A;Journal of Neural Transmission;2023-08-29

3. How does medicine Parkon® affect the MPTP-induced oxidation stress and MAO systems of the rats brain;Open Journal of Parkinson's Disease and Treatment;2021-05-25

4. Environmental Aspects of Alzheimer's and Parkinson's Diseases Neuropathologies;Research Anthology on Diagnosing and Treating Neurocognitive Disorders;2021

5. The relationships of vitamin D, vitamin D receptor gene polymorphisms, and vitamin D supplementation with Parkinson’s disease;Translational Neurodegeneration;2020-09-01